Although there was patient-related gene expression variation, of the 34 patients where we had both cancer and non-cancer samples, the majority (n = 31, 91%) had higher SFRP4 gene expression in the cancer samples (Fig. 2d). This evidence concerns the gene SFRP4 and cancer.